1-4 of 4
Peter Leidenmuehler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate

Gerald Hoebarth, Alexandra Kopic, Martin Wolfsegger, Cstat (RSS), Alexander Bauer, Peter L. Turecek, PhD, Peter Leidenmuehler, Karima Benamara, Werner Hoellriegl, Marietta Turecek
Journal: Blood
Blood (2016) 128 (22): 2590.
https://doi.org/10.1182/blood.V128.22.2590.2590
Published: 2016
Journal Articles

Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product

Veronika Ehrlich, Peter Leidenmuehler, Barbara Dietrich, Gerald Hoebarth, Tanja Ruthsatz, Peter L. Turecek, PhD, Martin Wolfsegger, Cstat (RSS), Alfred Weber, Herbert Gritsch, Werner Hoellriegl, Marietta Turecek
Journal: Blood
Blood (2016) 128 (22): 4977.
https://doi.org/10.1182/blood.V128.22.4977.4977
Published: 2016
Journal Articles

Concomitant Administration Of Activated Prothrombin Complex Concentrate and Recombinant Activated Factor VII At Low Doses Are Efficacious and Safe In Hemophilic Mice

Michael Dockal, PhD, Sabine Knappe, PhD, Peter Leidenmuehler, Christina Piskernik, DVM, Sylvia Tippl, Marlene Resch, DVM, Dagmar Verdino, DVM, Alexander Bauer, Werner Hoellriegl, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2013) 122 (21): 2353.
https://doi.org/10.1182/blood.V122.21.2353.2353
Published: 2013
Journal Articles

Preclinical Efficacy Testing of Baxter's Recombinant FVIIa

Alexandra Schiviz, PhD, John-Philip Lawo, PhD, Marlene Resch, Peter Leidenmuehler, Bettina Bischetsrieder, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Werner Hoellriegl, PhD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2010) 116 (21): 4659.
https://doi.org/10.1182/blood.V116.21.4659.4659
Published: 2010